Royal Emerald Pharmaceuticals
PrivateLast Round
Debt
Mar 8, 2022
Total Funding Raised
$16.98M
Company Overview
Royal Emerald Pharmaceuticals is a pharmaceuticals company that develops, manufactures, and supplies botanical-based medicines and cannabis-derived therapeutics for medical and scientific research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Compliance
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Royal Emerald Pharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
Royal Emerald Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 8, 2022 |
Key People
Founding team and executive leadership
Royal Emerald Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pelorus Equity Group | Debt |
Royal Emerald Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Royal Emerald Pharmaceuticals's valuation, stock price, and market status.
